Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
Bausch Health Companies Inc (NYSE: BHC) closed the day trading at $5.89 down -7.82% from the previous closing price of $6.39. In other words, the price has decreased by -$7.82 from its previous closing price. On the day, 4.96 million shares were traded. BHC stock price reached its highest trading level at $6.01 during the session, while it also had its lowest trading level at $5.5.
Ratios:
For a better understanding of BHC, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.25 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 2.05. For the most recent quarter (mrq), Quick Ratio is recorded 0.98 and its Current Ratio is at 1.31.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Piper Sandler on August 02, 2024, Downgraded its rating to Underweight and sets its target price to $3 from $9 previously.
On July 10, 2024, Raymond James started tracking the stock assigning a Mkt Perform rating and target price of $8.
Jefferies Upgraded its Hold to Buy on September 20, 2023, whereas the target price for the stock was revised from $9 to $16.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 13 ’25 when Paulson John bought 3,564,059 shares for $5.94 per share. The transaction valued at 21,170,510 led to the insider holds 32,791,702 shares of the business.
Paulson John bought 1,005,376 shares of BHC for $5,499,407 on Jun 12 ’25. The Director now owns 29,227,643 shares after completing the transaction at $5.47 per share. On Jun 11 ’25, another insider, Paulson John, who serves as the Director of the company, bought 1,029,098 shares for $5.24 each. As a result, the insider paid 5,392,474 and bolstered with 28,222,267 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BHC now has a Market Capitalization of 2185007360 and an Enterprise Value of 23680425984. As of this moment, Bausch’s Price-to-Earnings (P/E) ratio for their current fiscal year is 22.49, and their Forward P/E ratio for the next fiscal year is 1.35. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.34. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.22. Its current Enterprise Value per Revenue stands at 2.434 whereas that against EBITDA is 7.597.
Stock Price History:
The Beta on a monthly basis for BHC is 0.41, which has changed by 0.046181202 over the last 52 weeks, in comparison to a change of 0.18569505 over the same period for the S&P500. Over the past 52 weeks, BHC has reached a high of $9.85, while it has fallen to a 52-week low of $4.25. The 50-Day Moving Average of the stock is 0.29%, while the 200-Day Moving Average is calculated to be -13.20%.
Shares Statistics:
Over the past 3-months, BHC traded about 1.98M shares per day on average, while over the past 10 days, BHC traded about 1555170 shares per day. A total of 369.75M shares are outstanding, with a floating share count of 291.85M. Insiders hold about 21.02% of the company’s shares, while institutions hold 58.48% stake in the company. Shares short for BHC as of 1752537600 were 7436683 with a Short Ratio of 3.76, compared to 1749772800 on 8675986. Therefore, it implies a Short% of Shares Outstanding of 7436683 and a Short% of Float of 2.17.
